Individuals suffering from severe viral respiratory tract infections have recently emerged as
“at risk” groups for develo** invasive fungal infections. Influenza virus is one of the most …

The immune response to Candida species is shaped by the commensal character of the
fungus. There is a crucial role for discerning between colonization and invasion at mucosal …

Pulmonary infections caused by the mould pathogen Aspergillus fumigatus are a major
cause of morbidity and mortality globally. Compromised lung defences arising from …

Invasive fungal infections (IFIs) are an important cause of morbidity and mortality in
immunocompromised patients. Patients with hematological malignancies undergoing …

First reports of cases and case series of COVID-19-associated pulmonary aspergillosis
(CAPA) emerged during the first months of the pandemic. Prevalence rates varied widely …

Candida albicans is a major cause of bloodstream infection which may present as sepsis
and septic shock-major causes of morbidity and mortality world-wide. After invasion of the …

The trial was an investigator-initiated trial funded, in part, by Novartis and by an intramural
grant. Novartis had no role in the study design, the collection, analysis, and interpretation of …

Fungal diseases affect millions of humans annually, yet fungal pathogens remain
understudied. The mold Aspergillus flavus can cause both aspergillosis and fungal keratitis …

An improved understanding of the pathogenesis of Aspergillus infections has facilitated the
identification of host biomarkers that, if validated in well-designed prospective studies, could …

Pulmonary aspergillosis is a severe infectious disease caused by some members of the
Aspergillus genus, that affects immunocompetent as well as immunocompromised patients …